The effect of peripherally administered an giotensin II (AIl) on blood flow to choroid plexuses was examined in pentobarbital-anesthetized rats. The indica tor fractionation method with 1231_ or 1251-N-isopropyl-p iodoamphetamine as the marker was employed to mea sure blood flow. Basal blood flow to choroid plexus of the lateral cerebral ventricle (LVCP) (3.19 ± 0.23 ml g-I min -I) was lower than that to choroid plexuses of the third (3VCP) and fourth (4VCP) ventricles (3.90 ± 0.38 and 3.95 ± 0.36 ml g-I min -I, respectively). The effect of All on choroidal blood flow varied depending on pep tide dose and anatomical location of the choroidal tissue.
Summary: The effect of peripherally administered an giotensin II (AIl) on blood flow to choroid plexuses was examined in pentobarbital-anesthetized rats. The indica tor fractionation method with 1231_ or 1251-N-isopropyl-p iodoamphetamine as the marker was employed to mea sure blood flow. Basal blood flow to choroid plexus of the lateral cerebral ventricle (LVCP) (3.19 ± 0.23 ml g-I min -I) was lower than that to choroid plexuses of the third (3VCP) and fourth (4VCP) ventricles (3.90 ± 0.38 and 3.95 ± 0.36 ml g-I min -I, respectively). The effect of All on choroidal blood flow varied depending on pep tide dose and anatomical location of the choroidal tissue.
All infused intravenously at rates of 30 and 50 ng kg -1 min -I decreased blood flow to both L VCP and 4VCP by 12-20%. Both lower (10 ng kg -I min -I) and higher (100 and 300 ng kg -I min -I) All doses did not alter blood flow to LVCP and 4VCP. Blood flow to the 3VCP was not affected by any dose of the peptide used. In comparison, blood flow to cerebral cortex increased by 33% during Angiotensin II (AlI) plays an important role in the regulation of arterial blood pressure and mainte nance of body fluid and mineral homeostasis. This hormone exerts several centrally mediated effects brought about by the interaction of All with circum ventricular organs (CVOs) (Phillips, 1987; Johnson 143 intravenous All infusion at a rate of 300 ng kg -I min -I.
The choroidal blood flow-lowering effect of moderate All doses was abolished by both AT I (losartan) and AT 2 (PD 123319) receptor subtype antagonists (3 mg kg -I i.v.). To determine whether the hemodynamic changes observed in choroid plexuses with moderate All doses influence CSF formation, the ventriculocisternal perfusion was per formed in rats (under the experimental conditions de scribed) with Blue Dextran 2000 as the indicator. CSF production was not altered during intravenous infusion of All at a rate of 30 ng kg -I min -I. It is suggested that CSF formation is maintained in pathophysiological situations accompanied by increased plasma All levels, which im plicates a potential role for All in regulating ion and water balance in the CNS. Key Words: Angiotensin 11-Angiotensin II receptor subtypes-Cerebral cortical blood flow-Cerebrospinal fluid formation-Choroid plexus blood flow-Isopropyliodoamphetamine.
and Gross, 1993) . CVOs are positioned in the vicin ity of cerebral ventricles and possess fenestrated capillaries that allow the blood-borne substances to gain access into the CNS (Johnson and Gross, 1993) . The high density receptor sites for All have been localized in CVOs (Gehlert et aI., 1991; Tsut sumi and Saavedra, 1991) . Choroid plexuses are of ten classified as CVOs because of their anatomical location and the fenestration of their capillaries, similar to those of CVOs (Davson et aI., 1987) . All receptor sites have been reported to exist in the choroid plexus as well (Gehlert et aI., 1991; Tsut sumi and Saavedra, 1991) .
The choroid plexuses of all four cerebral ventri cles are the major source of the CSF. The process of CSF formation involves both plasma ultrafiltra tion through the choroidal capillary walls and active ion transport mechanisms in the choroidal epithe lium (Davson et aI., 1987; Johanson et aI., 1992) . Blood flow to choroid plexuses may influence CSF formation (Cserr, 1971) . The relationship between choroidal blood flow and rate of CSF production has not yet been established, however. Although the former parameter is altered by various hor mones, including All, as well as by the sympathetic nervous system (Wagerle et aI., 1986; Faraci et aI., 1988a,b; Maktabi et aI., 1990) , the possible influ ence of these peripheral stimuli on CSF production could be associated not only with their hemody namic actions, but also with their epithelium-related effects. This, therefore, complicates the analysis of the blood flow-CSF production relationship under in vivo conditions.
The principal aim of the present study was to investigate the effect of intravenously infused All (10-300 ng kg-I min-I) on blood flow to choroid plexuses. For comparison, blood flow to cerebral cortex was measured as well. We found that the effect of All on choroidal blood flow varies depend ing on both plasma peptide concentration and ana tomical location of the choroidal tissue. Generally, moderate plasma peptide concentrations lowered choroidal blood flow, whereas low and high plasma All levels did not change this parameter. We at tempted, therefore, to determine which All recep tor subtype (AT I or AT2) mediates the choroidal blood flow-lowering effect of moderate peptide doses by using recently discovered specific nonpep tide All antagonists (Timmermans et aI., 1993) . Fi nally, we evaluated the effect of peripheral admin istration of All at a moderate dose on CSF forma tion.
MATERIALS AND METHODS

General procedures
Adult male Sprague-Dawley rats (220--360 g) purchased from Charles River Breeding Laboratories (Wilmington, MA, U.S.A.) were used. They were housed in a temper ature-controlled room at 22°C with 12-h light cycle and maintained on standard pelleted rat chow and tap water ad libitum. Rats were anesthetized with intraperitoneal pentobarbital sodium at a dose of 50 mg kg -I. Atropine (50 fl.g kg -I) was administered subcutaneously to mini mize tracheobronchial secretion. A tracheostomy was performed and the trachea cannulated with a length of PE-240 tubing (Clay Adams, Parsippany, NJ, U.S.A.). For blood flow experiments, the following vessels were catheterized with PE-50 tubing: two femoral arteries for collection of blood samples and measurement of MABP, two femoral veins for administration of drugs and solu tions, and the external jugular vein for infusion of the radioactive marker. For CSF production experiments, only one femoral artery and two femoral veins were can nulated, followed by further surgical preparation as de-J Cereb Blood Flow Metab, Vol. 15, No. 1, 1995 scribed later. The animals were ventilated by means of a Harvard Apparatus Rodent Respirator (model 680; South Natick, MA, U.S.A.) after being paralyzed with d-tubo curarine (1 mg kg -I i.v.). Pa0 2 was maintained at 90--120 mm Hg by adjusting the inspired oxygen content, and Pac0 2 was kept at 33-39 mm Hg by adjusting the tidal volume and respiratory rate. A heating lamp was used to keep rectal temperature at -37°e.
Measurement of blood flow to choroid plexuses
Blood flow to choroid plexuses was measured by the indicator fractionation method with 1 2 3 1_ or 1 2 5I_N_ isopropyl-p-iodoamphetamine (IMP) as the marker. 1 2 31 _ labeled IMP was purchased from IMP Inc. (Houston, TX, U.S.A.), whereas 1 2 5I-labeled IMP was custom synthesized by Dr. P. A. Schubiger of the Paul Scherrer Institute (Villingen, Switzerland). IMP had a specific ac tivity of 6.67 Ci g-I and was provided in physiological solution (1 mCi ml-I). IMP (40--50 fl.Ci) was administered by rapid intrave nous infusion, and the animal was killed by decapitation 30 s later. A reference blood sample was continuously withdrawn from the femoral artery at a rate of 200 fl.l min -I with a Harvard Apparatus 22 infusion/withdrawal pump. Blood withdrawal was started 10 s before IMP administration and terminated at the time of decapitation. Choroid plexuses were removed separately and weighed on a Cahn C-31 electronic balance (Cerritos, CA, U.S.A.). Because of the small amount of plexus tissue «2 mg), there was appreciable loss of water during the period of time between excision of the tissue and its weighing. Therefore, an indirect method was used to evaluate the actual wet plexus weight; i.e., the semilog arithmically plotted weight of the tissue, recorded every 15 s for 1.75 min, was extrapolated to time 0 (Johanson et aI., 1976) . Blood flow was calculated according to the following formula: BF = (Ct X Qr)/C" where BF is blood flow (ml g-I min -I), Qr is rate of withdrawal of the ref erence blood sample (ml min -I), Ct is counts per minute per gram of tissue, and Cr is the total counts per minute in the reference blood sample. Tissue and blood samples were counted in a Beckman 5500 'Y-counter (Fullerton, CA, U.S.A.). In addition to measuring blood flow to cho roid plexuses, for comparison, blood flow to parietal ce rebral cortex was assessed as well.
All experimental procedures were started after a 30min stabilization period that followed surgical prepara tion. Immediately upon completion of the surgical prep aration, the animals were heparinized (200 U kg -I i. v.) and received the supplementary dose of pentobarbital (15 mg kg -I Lv.). Altogether 10 groups of rats were used. To determine whether blood-borne All exerts a dose dependent effect on blood flow to choroid plexuses, in five groups of animals, All (Peninsula Labs., Belmont, CA, U.S.A.) was administered intravenously at the fol lowing rates: 10 (n = 6), 30 (n = 8), 50 (n = 9), 100 (n = 7), and 300 (n = 8) ng kg -I min -I (volume infused was 10 fl.l min -I) . In the control group (n = 12), the vehicle (0.9% NaCl) was administered instead of All. Blood flow was measured at 10 min of All or vehicle infusion. To evaluate the role played by AT I and AT 2 receptor sub types in mediating the choroidal blood flow-lowering ef fect of All, respective nonpeptide All antagonists losar tan (DuPont, Wilmington, DE, U.S.A.) (n = 6) and PD 123319 (Parke-Davis, Ann Arbor, MI, U.S.A.) (n = 9) were administered intravenously at a dose of 3 mg kg -I.
Ten minutes later, intravenous infusion of All at a rate of 30 ng kg -1 min -1 was started. Blood flow was measured at 10 min of All infusion. The effect of losartan and PD 123319 on basal choroidal blood flow was studied in groups of six and nine animals, respectively. In these latter experiments, blood flow was measured 20 min after administration of antagonists (3 mg kg-I i.v.). In all ex periments in which the pressor response to intravenous infusion of All occurred, MABP was controlled by blood withdrawal of up to -20 ml kg-I with the highest All dose.
Measurement of CSF production
CSF formation rate was measured by a modification of the ventriculocisternal perfusion method of Pappenhe imer et ai. (1962) . For this purpose, the animals, after the initial surgical preparation, were mounted in a stereotaxic frame and two stainless-steel cannulas (27 gauge) were introduced into the lateral cerebral ventricles (3.5 mm caudal and 3 mm lateral to bregma and 2-3 mm below the level of the dura at a right angle to the surface of the skull). Artificial CSF was infused through these cannulas at a rate of 2 ILl min -1 for each ventricle (Harvard Ap paratus 22 infusion/withdrawal pump), while intraventric ular pressures were continuously monitored by means of T-connectors inserted into the infusion lines. These pres sures were kept at a level of 2-3 mm Hg. CSF was col lected through a stainless-steel cannula (27 gauge) in serted into the cisterna magna.
Artificial CSF had the following composition: NaCl125 mM, KCl 2.5 mM, CaCl 2 1.2 mM, MgCl 2 0.9 mM, NaHC0 3 25 mM, Na 2 HP04 0.5 mM, KH 2 P04 0.5 mM, glucose 3.7 mM, urea 6.5 mM. This fluid also contained the indicator Blue Dextran 2000 (Sigma Chemical Co., St. Louis, MO, U.S.A.) at a concentration of 5 mg ml-I. CSF samples were collected at 20-min intervals, and the concentration of Blue Dextran in the samples was deter mined colorimetrically by measuring absorbance at 620 nm. Before performing these measurements, samples were processed as previously described (Chodobski et al., 1992b) . CSF formation rate was calculated according to the following formula: Vf = Vi X [(Ci -Co)/Co], where Vf is CSF formation rate, Vi is rate of infusion of artificial CSF, and Ci and Co are concentrations of Blue Dextran in inflow and outflow fluid, respectively.
Since there is usually a gradual decrease in CSF for mation rate during the course of the ventriculocisternal perfusion (Chodobski et aI., 1992b) , the value of CSF production determined after 3 h of perfusion was arbi-trarily chosen, on the assumption that the nascent CSF and the perfusate are well mixed at this time. There was, therefore, a separate series of control experiments per formed to be compared with the experimental group. To evaluate the effect of blood-borne All on CSF produc tion, the peptide was administered intravenously to six rats at a rate of 30 ng kg-I min -1 (volume infused was 5 ILl min -1), with the intravenous infusion commencing si multaneously with the ventriculocisternal perfusion. MABP was controlled by blood withdrawal (up to -4 ml kg-I). In control experiments (n = 6), the vehicle (0.9% NaCl) was administered intravenously instead of All. During the course of the ventriculocisternal perfusion, loss of fluids was counterbalanced by intravenous infu sion of lactated Ringer solution to provide the total fluid replacement of 3 ml kg -1 h -1, and anesthesia was main tained by administering supplementary doses of pento barbital (15-25 mg kg-I h -1 i. v.). The level of anesthesia was controlled by observing changes in MABP in re sponse to pressure applied to a hind limb or tail.
Statistical analysis
Results are presented as means ± SD. For statistical analysis of data, one-way analysis of variance was used. The Dunnett and Newman-Keuls tests were employed to make multiple comparisons between the average control value and other means and among all means, respec tively. p < 0.05 was considered statistically significant. Table 1 shows blood gases in control and AIl infused animals. These parameters were maintained at comparable levels in all groups of rats. MABP did not differ among the groups.
RESULTS
Blood flow to choroid plexuses and cerebral cortex
Control blood flow to choroid plexus of the lat eral cerebral ventricle (LVCP) (3.19 ± 0.23 ml g-1 min -1) was found to be significantly lower (p < 0.01) than that to choroid plexuses of the third (3VCP) and fourth (4VCP) ventricles (3.90 ± 0.38 and 3.95 ± 0.36 ml g-1 min-I, respectively). There was no difference in control blood flow values be tween the 3VCP and 4VCP (Fig. 1) . The effects of blood-borne All on blood flow to choroid plexuses varied depending on plasma peptide level and ana- Values are means ± SD. Cortical blood flow was measured at 10 min of All infusion. In control experiments, the vehicle (0.9% NaCl) was administered instead of All. a p < 0.01, compared with control (Dunnett test). :;:
tomical location of the choroidal tissue ( Fig. 1 ). Blood flow to the LVCP decreased significantly (p < 0.01) by 15 and 20% during intravenous All in fusion at rates of 30 and 50 ng kg -1 min -I, respec tively. These rates of intravenous All administra tion were associated with qualitatively similar changes in blood flow to the 4VCP. Thus, this pa rameter decreased significantly (p < 0.05) by 13% and tended to decrease by 12% with intravenous All infusion rates of 30 and 50 ng kg -1 min -I, re spectively. Both lower (10 ng kg -1 min -I) and higher (100 and 300 ng kg -1 min -I) All doses did not alter blood flow either to LVCP or to 4VCP. Blood flow to the 3VCP was not affected by any dose of the peptide used. Blood flow to cerebral cortex increased signifi cantly (p < 0.01) by 33% during intravenous All infusion at a rate of 300 ng kg -1 min -1 as compared with control (Table 1) . Lower doses of All were found not to alter cortical blood flow (Table 1) . As the increase in cortical blood flow observed with the highest All dose could be in part associated with the slightly higher Paco2 level in All-infused animals than in control group (by �2 mm Hg; Table  1 ), we corrected all cortical blood flow values for P aco2 variability based on the linear regression analysis of the relationship between P aco2 and cor tical blood flow performed on pooled data obtained under control conditions and during intravenous All infusion at rates ranging between 10 and 100 ng kg-I min-I (y = 0.0255x -0.26; r = 0.615, p < 0.001). Subsequent statistical analysis of corrected cortical blood flow values still showed a significant difference (p < 0.05) between animals infused intra venously with All at a dose of 300 ng kg -1 min -1 and the control group.
To evaluate the role played by AT I and AT2 re ceptor subtypes in mediating the choroidal blood flow-lowering effect of moderate All doses, the re spective nonpeptide All antagonists losartan and PD 123319 were used. Intravenous administration of losartan was accompanied by an initial fall in MABP (by 20-30 mm Hg), which developed within 4-5 min after antagonist injection. Within 10 min after losartan administration, MABP stabilized at a level that was lower by 5-10 mm Hg from baseline MABP values. Subsequent intravenous infusion of All did not change MABP. Although the levels of MABP in two groups of animals injected with losa rtan were somewhat lower than that found under control conditions, the differences were not statis tically significant (Table 2 ). In comparison, PD 123319 upon intravenous administration did not change MABP. This antagonist also did not alter the pressor response observed following intravenous All infusion. The levels of MABP in two groups of Values are means ± SO. All, angiotensin II. Losartan and PO 123319 are AT I and AT2 receptor subtype antagonists, respectively. They were administered intravenously at a dose of 3 mg kg-I, 10 min before start of intravenous All infusion. Cortical blood flow was measured at 10 min of All infusion. For comparison, the control group and rats infused only with All are shown as well. Table 2) . Both losartan and PD 123319 abolished the decrease in blood flow to the L VCP and 4VCP observed dur ing intravenous infusion of All at a rate of 30 ng kg -1 min -1 (Fig. 2) . The effect of blockade of All receptors was investigated with only one All dose (30 ng kg-1 min -1) since the higher peptide dose (50 ng kg-1 min -I) was found to exert qualitatively similar effects on choroidal blood flow (see Fig. 1 ). Neither losartan nor PD 123319 by itself altered basal choroidal blood flow (Fig. 2) . Both nonpep tide All antagonists did not affect cortical blood flow ( Table 2) .
CSF production
Physiological parameters monitored during the course of the experiments are shown in Table 3 . Blood gases were maintained to similarity in all rats. There was no difference in MABP between control and All-infused animals.
CSF formation rate was not altered in animals infused intravenously with All at a rate of 30 ng kg-I min -1 as compared with the vehicle-infused control group (Table 3) . The values of CSF produc tion determined at 3 h of the ventriculocisternal per fusion did not differ from those obtained at 2 h (data not shown). The latter finding indicates, therefore, that the gradual decrease in CSF production rate observed during the ventriculocisternal perfusion is less of a problem in the rat than other species (see Chodobski et aI., 1992b) .
DISCUSSION
Blood flow
Methodology. Blood flow was measured by the indicator fractionation method with IMP as the marker. IMP has previously been used to measure blood flow to highly perfused brain regions, includ ing choroid plexus (Lear et aI., 1982; Bryan et aI., 1988; Williams et aI., 1991 ; Szmydynger-
LVCP 3VCP 4VCP
Chodobska et aI., 1994). The reasons for using this marker were previously discussed (Szmydynger Chodobska et aI., 1994); the primary consideration is that IMP, unlike freely diffusible indicators, e.g. , iodoantipyrine, is trapped within the tissue. The se questration of the marker precludes its diffusional loss, which is crucial if one measures blood flow to choroid plexuses surrounded by the CSF.
Effects of All on choroidal blood flow. The new
finding in the present study is that the effects ex erted by blood-borne All on blood flow to choroid plexuses depend on both plasma peptide concentra tion and anatomical location of the choroidal tissue. Thus, All at moderate doses was found to decrease blood flow to both LVCP and 4VCP, whereas with low and high rates of peptide administration, no sig nificant changes in this parameter were observed. In comparison, blood flow to the 3VCP was not altered by blood-borne All.
The following rates of intravenous All infusion were used, 10, 30, 50, 100, and 300 ng kg-1 min -I, which according to data of Mann et ai. (1980) would result in plasma peptide concentrations in the rat of � 120, �270, �420, �800, and �2300 pg ml-I, re spectively. The first four All infusion rates covered the plasma peptide levels observed in 12-48 h of 3.40 ± 0.41
Values are means ± SD. CSF formation rate was determined after 3 h of ventriculocisternal perfusion. All or vehicle (0.9% NaCl, control) infusion was started simultaneously with perfu sion of the ventricular system. dehydration both in normal and in hereditary dia betes insipidus (Brattleboro) rats, in animals fed a low sodium diet, and in renal hypertension (Mann et aI., 1980; Huang et aI., 1989) . The highest peptide concentration was close to that found in malignant renal hypertension (Mann et aI., 1980) or could have been pharmacological, although almost twofold higher plasma All levels were observed in inferior vena cava-ligated rats following All receptor block ade (Mann et aI., 1981) . Our observations suggest, therefore, that choroidal blood flow is lowered by 12-20% in both water-and sodium-deprived rats. It is not clear, however, whether choroidal blood flow would be decreased in renal hypertensive animals as well because of the possible counteracting effect of elevated MABP. Autoregulation of choroidal blood flow has not yet been established.
Our results vary from those of Maktabi et ai. (1990) who found 39 and 57% decreases in blood flow to L VCP in rabbits during intravenous infusion of All at rates of 30 and 100 ng kg-I min -I, respec tively. Their All infusion rates resulted in plasma peptide concentrations of -580 and -2,680 pg ml-l, respectively (Maktabi et aI., 1990) . The quan titative differences between both studies could be species related and/or could be associated with the use of different anesthesia.
Regional differences in choroidal blood flow.
Blood flow to both 3VCP and 4VCP was found to be consistently higher than that to LVCP in all animals studied, which agrees with the observations made in our previous ontogeny study where blood flow to 4VCP was higher than that to LVCP both in adult and in juvenile rats (Szmydynger-Chodobska et aI., 1994) . By comparison, Williams et ai. (1991) re ported similar levels of blood flow to all choroid plexuses. Furthermore, the values of choroidal blood flow obtained by us were lower than those observed in rats by other authors using IMP as the marker (Lear et aI., 1982; Williams et aI., 1991) . The reason for these differences is not clear. The use of different techniques (quantitative autoradiography versus separate tissue collection) and the influence of anesthesia are to be considered. Importantly, however, Lear et ai. (1982) noted that barbiturate anesthesia did not alter choroidal blood flow.
Differences among choroid plexuses with regard to baseline blood flow values and to the responses of this parameter to All could be accounted for by dissimilarities of the complexity of their microvas cular beds and/or different regulation, both hor monal and neurogenic, of blood flow to these tis sues. Recent observations from this laboratory in dicate that All controls choroidal blood flow by interacting with both the sympathetic nervous sys-J Cereb Blood Flow Metab, Vol. 15, No. 1, 1995 tern and nitric oxide (NO) synthesis (Chodobski et aI., 1993) . Moreover, Lindvall (1979) provided convincing evidence that choroid plexuses differ with respect to the density of their sympathetic in nervation. Uneven patterns of changes in baseline values of blood flow to LVCP vs. 4VCP found in postnatally maturing rats (Szmydynger-Chodobska et aI., 1994) could also be associated with differ ences in development of the sympathetic innerva tion among choroid plexuses (Lindvall and Owman, 1978 ).
An intriguing observation was the lack of changes in blood flow to 3VCP in response to blood-borne All. Our preliminary studies showed, however, that in rats subjected to chronic (7 days) bilateral supe rior cervical ganglionectomy, blood flow to all cho roid plexuses was decreased during intravenous All infusion at a rate of 30 ng kg-I min -I. This surgical intervention eliminated the sympathetic choroidal innervation (Edvinsson et aI., 1974) and unmasked the blood flow-lowering effect of All in the 3VCP. The latter findings suggest, therefore, that All con trols choroidal blood flow not only by interacting with the sympathetic nervous system and NO syn thesis, as mentioned, but also by directly affecting choroidal vasculature. Such complex interactive mechanisms appear to be responsible for the lack of changes in blood flow to the 3VCP in response to All and for the peculiar dose-response relationship between plasma All content and blood flow to LVCP and 4VCP, where moderate peptide doses lowered, while low and high peptide doses did not alter, choroidal blood flow.
All receptor subtypes. Recent discovery of spe cific All receptor antagonists resulted in pharmaco logical characterization of two distinctive All re ceptor subtypes, AT I and AT2 (Timmermans et aI., 1993) . The AT I receptor, which is blocked by losa rtan, has been found to mediate several intracellular All actions, including production of inositol 1,4,5trisphosphate and diacylglycerol, mobilization of Ca 2 +, and inhibition of adenylyl cyclase activity. The AT 2 receptor is blocked either by non peptide antagonists, PD 123319 and its analogues, or by the peptide antagonist CGP 42112A (Timmermans et aI., 1993) . At present, the physiological importance of AT 2 receptors is not clear. The AT 2 receptor sub type has been reported to mediate an All-induced decrease in cyclic GMP both in rat pheochromocy toma (PC12W) cells and neonatal neuron cultures (Sumners et aI., 1991; Bottari et aI., 1992) , but these observations have not been confirmed (Webb et aI., 1992) . In spite of this, there is a growing body of evidence derived from physiological experiments indicating a functional role of AT 2 receptors (Hog-arty et al., 1992; Keiser et al., 1992 Keiser et al., , 1993 Toney and Porter, 1993; Widdop et al., 1993) .
In the present study, both losartan and PD 123319 were found to abolish the choroidal blood flow lowering effect of moderate doses of All. The pos sibility that PD 123319 at the dose used (3 mg kg-I) could interact with the AT I receptor subtype is un likely, since this antagonist neither altered baseline MABP nor interfered with the pressor response to intravenous All infusion.
The autoradiographic All binding studies of rat brain indicate that the choroid plexus contains only the AT ! receptor subtype (Oehlert et al., 1991; Tsut sumi and Saavedra, 1991) , although in the choroid plexus of the hamster, as much as � 30% of a total number of All binding sites belongs to the AT 2 re ceptor subtype (Saylor et al., 1992) . Our finding with PD 123319 is unexpected in view of the lack of evidence for AT 2 receptors in rat choroid plexus. It is, however, possible that with autoradiography, a small, but functionally important population of AT2 receptors in rat choroid plexus could not be de tected. Alternatively, in our experiments, All also activated some other receptors blocked by PD 123319 that could not be differentiated by the ligand displacement analysis employed in autoradio graphic studies (Oehlert et al., 1991; Tsutsumi and Saavedra, 1991) . Indeed, Ernsberger et al. (1992) recently identified a new All receptor subtype with high affinity to PD 123319, low affinity to losartan, and little affinity to COP 42112A. Similar to AT ! , the new All receptor subtype has been found to be coupled to O-protein and to mediate an All-induced increase in intracellular Ca 2 + and inhibition of ad enylyl cyclase activity (Ernsberger et al., 1992; Madhun et al., 1993) . Interestingly, the effects of blockade of All re ceptors with losartan and PD 123319 were not ad ditive, since each antagonist abolished the action of the moderate All dose on choroidal blood flow. As discussed previously, our preliminary observations indicate that All controls choroidal blood flow by multiple mechanisms involving both direct vascular peptide action and the interactions of All with the sympathetic nervous system and NO synthesis. Further work will be required to determine how losartan and PD 123319 could interfere with these mechanisms.
Effects of All on cerebral cortical blood flow.
Baseline values of cortical blood flow obtained in this study were comparable with those observed by Otsuka et al. (1991) in pentobarbital-anesthetized rats. This parameter was found not to change during intravenous All infusion at rates ranging from 10 to 100 ng kg -! min -!. However, the highest dose of All used (300 ng kg -! min -!) significantly in creased blood flow to cerebral cortex. This latter finding is in line with that of Tamaki et al. (1992) who reported a 39% increase in cerebral blood flow following intracarotid infusion of All at a rate of 5 fLg min -!. These authors also found that CMR02 did not change during All administration and that cyclooxygenase products were not involved in the cerebral vasodilative peptide action. All appears not to cross the blood-brain barrier readily (Hard ing et al., 1988) , and it is therefore possible that an increase in cerebral blood flow during intravenous All infusion was mediated by the endothelium related vasodilative mechanisms. Haberl et al. (1990) found that methylene blue, a specific NO synthase inhibitor, which also inhibits the guanylyl cyclase activity when used at higher doses (Mayer et al., 1993) , reverses All-induced pial arteriolar di lation. This dilation was also abolished following functional damage of pial arteriolar endothelium (Haberl et al., 1990) . Recent observations of Zarahn et al. (1992) indicate that All-induced NO produc tion in NIE-115 neuroblastoma cells is mediated by AT ! and partially by AT2 receptor subtypes.
CSF fo rmation
Production of CSF involves both plasma ultrafil tration through the choroidal capillary walls and ac tive ion transport mechanisms (mostly Na + and CI-) in the choroidal epithelial cells (Davson et al., 1987; Johanson et al., 1992) . Choroidal blood flow is believed to influence CSF formation by limiting the amount of water and electrolytes available for transfer from the choroidal vascular compartment (Cserr, 1971) ; however, the relationship between blood flow to choroid plexuses and CSF formation rate has not yet been elucidated.
The process of plasma ultrafiltration in the cho roid plexus appears to be analogous to that taking place in glomerulus (Baylis and Brenner, 1978) . In this part of the nephron, filtration rate is dependent on blood flow, but the relationship between these two variables is nonlinear, and at high perfusion rates, filtration changes proportionally less than blood flow. This nonlinearity results from filtration pressure disequilibrium occurring at high blood flow rates, when the oncotic pressure g�adient across the capillary wall is lower than the hydro static pressure difference at the end of the glomer ular capillary network.
CSF production was not altered by All infused intravenously at a rate of 30 ng kg -! min -!, even though this All dose moderately decreased (by 13-15%) choroidal blood flow. During intravenous ad ministration of a higher All dose (50 ng kg -! min -I), which exerted qualitatively similar effects on choroidal blood flow, CSF formation rate also did not differ from control (3.37 ± 0.65 /-11 min -I, n = 4) (data not shown). It is possible that filtration pressure disequilibrium exists in the choroid plexus, which would result in an attenuation of the changes in CSF formation rate in response to cho roidal hemodynamic perturbations. A small diminu tion in CSF production accompanying a moderate decrease in choroidal blood flow probably could not be detected with the ventriculocisternal perfusion method. The choroidal epithelium-related action of All, similar to that observed in kidney and intestine (Harris and Navar, 1985; Levens, 1985) , and the effect of the peptide on extrachoroidal CSF sources (Cserr, 1984) should be considered as well, how ever. In this context, it is worth noting that during water deprivation, a pathophysiological situation accompanied by moderately increased plasma All concentrations (Mann et al., 1980) , production of CSF was maintained at a level that was not different from that found in the water-replete state (Chodob ski et al., 1992a) . Further work will be required to determine the mechanisms underlying these obser vations.
Interestingly, Maktabi et al. (1993) found in rab bits that intravenous infusion of All at a rate of 100 ng kg-I min -I decreased CSF formation. The spe cific peptide All antagonist saralasin had action similar to that of All, but it was also able to block the inhibitory effect of All on CSF production (Maktabi et al., 1993) . Further research into such findings is likely to clarify the differences observed in their study and our present investigation.
CONCLUSIONS
We showed that the effects of blood-borne All on blood flow to choroid plexuses vary depending on plasma peptide concentration and anatomical loca tion of the choroidal tissue. Blood flow to both L VCP and 4VCP was found to be lowered by mod erate doses of All, while no changes in blood flow to the 3VCP were observed with any dose of the peptide used. The blood flow-lowering effect of moderate All doses was abolished by both AT 1 and AT2 receptor subtype antagonists. Unlike choroidal blood flow, CSF production was not altered during intravenous administration of moderate All doses. It is suggested that CSF formation is maintained in pathophysiological situations accompanied by in creased plasma All levels. This implicates a poten tial role for All in regulating ion and water balance in the CNS.
In the present study, we evaluated the hemody-J Cereb Blood Flow Metab, Vol. 15, No. J, 1995 namic and CSF formation adjustments of the cho roidal tissue in response to elevated plasma All lev els. However, in various pathophysiological situa tions that are accompanied by high plasma All concentrations, the central angiotensin system is activated as well (Simon-Oppermann et al., 1986; Qadri et al., 1994) , Maktabi et al. (1991) have dem onstrated in rabbits that intracerebroventricular ad ministration of All can decrease blood flow to cho roid plexus. In view of species-related differences with regard to both choroidal blood flow and CSF formation responses to circulating All, it would be interesting to perform an analogous investigation in the rat.
